Monday, February 27, 2012

Brief look at health insurance laws in US

Other highlights in the country's history of health insurance include:

The Health Insurance Portability and Accountability Act. Produced as a bipartisan compromise in 1996, it guaranteed that workers could continue coverage from their jobs even after getting laid off and that spouses could retain coverage even after a divorce. But you had to pay the full cost of the coverage — your premium and the company's premium — plus a 2% fee.

Monday, May 2, 2011

Using Proscar For Treating Men With Urinating Problem

It also removes focus in the musculus of bladder neck, prostrate hence making micturition easier. Flomax is classified below this drug category. It relaxes muscles that are victimised for urination process. All such multitude who have from micturition problems will get Flomax helpful. Patients miserable from magnified flat benefit by the use of Flomax.

Even if you get any allergy to this dose, you should stoppage off from Flomax. For the get-go clip the patient may spirit giddiness and mightiness fifty-fifty fainthearted. In showcase the patient has to thrust or ferment on lowering machineries , moldiness be real careful if he is on Flomax . Avoid standing for long time or involve with expectant strong-arm activities in hot surroundings.

Thursday, April 28, 2011

Not all pneumonia patients need a chest X-ray

Pneumonia patients who are under 50 and don't smoke don't need chest X-rays to look for lung cancer, suggests a new study from Canada.

The finding goes against most guidelines for pneumonia treatment, which say that patients should have the X-rays to rule out lung cancer as the hidden cause of the pneumonia.

It also comes in the midst of recent research suggesting that radiation from chest scans might increase the risk of some cancers, including breast cancer.

"If you're over 50 years of age and a smoker you do need a follow-up chest X-ray," Dr. Eric Mortensen, who has studied pneumonia and lung cancer at the University of Texas Health Science Center at San Antonio, told Reuters Health.

Sunday, April 17, 2011

Vaccine in Development Could Cure Cat Allergies

Sniffly-nosed kitten-lovers rejoice: A new vaccine could soon banish allergies to cats.

The vaccine isn't ready for prime time yet, but a new study finds that the shots are safe, researchers reported March 31 in the Journal of Allergy and Clinical Immunology. They're also effective at reducing allergic reactions, the researchers reported.

About 10 percent of peopleare allergic to cats. Currently, the only solutions are to stay far away from felines or to get multiple injections of kitty allergens to help the body build up a tolerance. But that process can take years, wrote McMaster University immunologist and study researcher Mark Larche.

Monday, March 28, 2011

Sportsmen select Propecia Pills Online

More than ten geezerhood ago, finasteride was approved for the treatment of phalacrosis. Now there is another brand describe of the dose – Propecia.

For a foresighted meter, scientists believed that the drive of manly practice baldness was solitary dihydrotestosterone (on with genetical factors), so later the discharge of Propecia no one hasn't doubt that finasteride testament be used for this purpose. It was a breakthrough for men wretched from pilus passing.

Saturday, March 26, 2011

What is use of Generic Nexium

Whether vernacular or rarefied, if the supra note Nexium Side Effects turn troublesome or prevail for long clock, immediately curb with your fix.

Also there are sure antibiotics exploited in handling of ulcers, when consumed along with Nexium can suffer life menacing incline effects. Consult with your physician or druggist earlier using any otc medicament patch fetching Nexium.

Thursday, March 24, 2011

Gilead HIV drug as effective as Mercks in trial

Gilead Sciences Inc said on Wednesday that its experimental HIV drug elvitegravir proved as effective as a drug made by Merck & Co in a late-stage clinical trial.

The trial showed that after 48 weeks of treatment, dosed once daily, elvitegravir was as effective as Merck's Isentress, which is dosed twice daily in combination with other antiretroviral drugs. Gilead's shares rose 2.7 percent to $41.53 in midday trading.

Discontinuation rates caused by adverse events were comparable in both arms of the study, the company said. Gilead plans to submit the data for presentation at a scientific conference later this year. Elvitegravir is designed to block the ability of the HIV virus to integrate into the genetic material of human cells.